US EditionFIRST AID: US firms look to Chinese biotech boom
Summary by EURACTIV
3 Articles
3 Articles
All
Left
1
Center
1
Right
The world of finance on Wall Street has been targeting a little-known company: Regencell Bioscience Holdings. This Hong Kong-based firm specializing in traditional Chinese medicine has seen its actions listed in the United States skyrocketing 398% during the first two days of the week. This boost adds to the impressive 60,000 percent increase so far this year. While this phenomenon has perplexed more than one, the details behind this growth may …
Coverage Details
Total News Sources3
Leaning Left1Leaning Right0Center1Last UpdatedBias Distribution50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium
